LBT: Placement Supports APAS Pharma & EU Expansion

LBT INNOVATIONS LIMITED

• Australian medical technology company LBT Innovations has secured a $1.5 million Share Placement Agreement with Lind Global Fund II, LP.
• The funds raised will support commercialisation activities for APAS® Pharma and Thermo Fisher distribution expansion to 35 countries globally.
• The cash position is approximately $3.1 million following the receipt of Placement proceeds, with further cash inflows expected through to December 2023.

2023-03-20 09:53:00

LBT: Astrazeneca Partners LBT For Apas Pharma Development

LBT INNOVATIONS LIMITED

1. AstraZeneca engages LBT following successful APAS® Pharma proof-of-concept
2. Supports LBT’s goal to automate pharmaceutical microbial quality control testing globally
3. Funded development project - ~AUD$1m to be received based on achieving technical milestones

2023-01-09 08:49:00